SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Jubilant Pharmova - Quaterly Results

16 May 2025 Evaluate
The revenue for the March 2025 quarter is pegged at Rs. 2173.00 millions, about 5.59% up against Rs. 2058.00 millions recorded during the year-ago period.Net Profit of the company move down -58.15% to Rs. 136.00  millions from Rs. 325.00 millions  in the same quarter last year.A decline of 439.00 millions was observed in the OP in the quarter ended March 2025 from 623.00 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 2173.00 2058.00 5.59 7457.00 7847.00 -4.97 7457.00 7847.00 -4.97
Other Income 179.00 501.00 -64.27 996.00 1034.00 -3.68 996.00 1034.00 -3.68
PBIDT 439.00 623.00 -29.53 1317.00 1199.00 9.84 1317.00 1199.00 9.84
Interest 70.00 81.00 -13.58 298.00 299.00 -0.33 298.00 299.00 -0.33
PBDT 369.00 542.00 -31.92 907.00 900.00 0.78 907.00 900.00 0.78
Depreciation 134.00 127.00 5.51 531.00 483.00 9.94 531.00 483.00 9.94
PBT 235.00 415.00 -43.37 376.00 417.00 -9.83 376.00 417.00 -9.83
TAX 99.00 90.00 10.00 184.00 101.00 82.18 184.00 101.00 82.18
Deferred Tax 17.00 22.00 -22.73 -14.00 33.00 -142.42 -14.00 33.00 -142.42
PAT 136.00 325.00 -58.15 192.00 316.00 -39.24 192.00 316.00 -39.24
Equity 159.00 159.00 0.00 159.00 159.00 0.00 159.00 159.00 0.00
PBIDTM(%) 20.20 30.27 -33.26 17.66 15.28 15.59 17.66 15.28 15.59

Jubilant Pharmova Share Price

907.00 -4.60 (-0.50%)
20-Apr-2026 14:54 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.15
Dr. Reddys Lab 1234.50
Cipla 1232.65
Zydus Lifesciences 938.40
Lupin 2329.85
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×